Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Breaking News

Related Searches:
November 11, 2010
Watson Pharmaceuticals’ Eden Biodesign, Ltd., has entered a non-exclusive vendor network agreement with Crucell, under which Eden Biodesign becomes an authorized provider of process development and cGMP manufacturing services using Crucell’s P  Read More »
November 11, 2010
Richard Walovitch, Ph.D. has been named president of WorldCare Clinical, LLC (WCC).  Read More »
November 11, 2010
Centocor Ortho Biotech, Inc. has submitted an sBLA to the FDA to expand the Simponi label to include the inhibition of the progression of structural damage and maintenance of signs and symptoms of active psoriatic arthritis (PsA).  Read More »
November 10, 2010
Growth in the quarter was attributed to growth in Lab Services and Manufacturing Services.  Read More »
November 10, 2010
The CDC has selected Accenture as a main contractor for a full range of IT services and solutions to support its global public health initiatives.  Read More »
November 10, 2010
Dr. Lawrence S. Olanoff, president and chief operating officer of Forest Laboratories, will retire effective December 31, 2010. Additionally, the company has made several executive management promotions.   Read More »
November 9, 2010
Total contract revenue for the quarter was $42.9 million (+8%).  Read More »
November 9, 2010
Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%).  Read More »
November 9, 2010
Dr. Manfred Weiler has been appointed vice president of Alliance Development for INC Research, Inc.   Read More »
November 8, 2010
WuXi PharmaTech has been awarded a certificate of Good Laboratory Practice (GLP) compliance for its toxicology facility in Suzhou, from the State Food and Drug Administration (SFDA), China's regulatory authority.  Read More »
November 8, 2010
Eli Lilly and Co. has signed a definitive merger agreement to acquire Avid Radiopharmaceuticals, Inc., a developer of novel molecular imaging compounds, for an upfront payment of $300 million.  Read More »
November 8, 2010
Bristol-Myers Squibb and AstraZeneca received approval from the FDA for Kombiglyze XR for the treatment of type 2 diabetes in adults.   Read More »
November 8, 2010
Dr. David Pushett has been appointed director of global business development at Porsolt.   Read More »
November 8, 2010
Mills to step down as CEO, retain chairman role  Read More »
November 5, 2010
Eli Lilly and Co. received approval from the FDA for Cymbalta (duloxetine HCl) for the management of chronic musculoskeletal pain.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On